Biotron publishes SARS research
Thursday, 11 November, 2004
The researchers at Biotron and the John Curtin School of Medical Research at ANU showed that the SARS coronavirus E protein forms ion channels.
Based on the research, Biotron has developed a screening test for the E protein and has screened its compound library for activity against the SARS E protein as well as other members of the coronavirus family, which are responsible for about 25 per cent of colds as well as other diseases. The company has identified a number of compounds with good activity, which are able to inhibit the replication of the SARS virus.
The work has been supported by a Commonwealth government BIF grant awarded to Biotron in November last year to support the development of the company's Virion platform technology.
Shingles vaccine may reduce risk of heart attack and stroke
Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...
Perioperative trial offers insights into brain cancer treatment
Victorian brain cancer researchers have used an innovative process to learn how a new drug...
New molecular mechanism found for depression
Depression may not only result from simple neuronal damage but can also arise from the...
